Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.100.40 CHF
Change Today +0.40 / 0.40%
Volume 3.9M
NOVN On Other Exchanges
Symbol
Exchange
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 11:43 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph Jimenez Jr., MBA

Chief Executive Officer, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 19 board members in 3 different organizations across 18 different industries.

See Board Relationships
55SFr.12,648,490
As of Fiscal Year 2014

Background*

Mr. Joseph Jimenez, Jr., also known as Joe, MBA serves as Chief Executive Officer of Novartis Vaccines and Diagnostics, Inc. Mr. Jimenez has been the Chief Executive Officer at Novartis AG since February 1, 2010. Mr. Jimenez serves as the Chief Executive Officer of Novartis International AG and Novartis India Limited. He served as the Chief Executive of Global Pharmaceuticals Business at Novartis Pharmaceuticals Corporation (Novartis Corporation). He served as the Chief ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Vice President of the Board
2015-Present
Director

Education*

BA 1982
Stanford University
MBA 1984
University of California Berkeley

Other Affiliations*

Annual Compensation*

SalarySFr.2,060,500
BonusSFr.4,018,084
Total Annual CompensationSFr.6,078,584

Stock Options*

Long Term Incentive PlanSFr.6,181,504
All Other CompensationSFr.388,402
Total Number of Options157,266

Total Compensation*

Total Annual Cash CompensationSFr.6,466,986
Total Short Term CompensationSFr.6,078,584
Other Long Term CompensationSFr.388,402
Total Calculated CompensationSFr.12,648,490
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.100.40 CHF +0.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.7M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.